The technology of the 3D printing joins the possibility of using the cells as inkto obtain organoids of human brainuseful for study diseases And experiment with drugs: the Ceres project of the Italian Institute of Technology, which also opens the way to the personalized medicine of the future thanks to the possibility of using cells taken directly from patients and develop like this Tailor -made therapies. Ceres will involve the Iit research centers in Naples, Rome and Aosta and has a expected duration of 18 months.
Unlike the Traditional 3D printerswhich employ plastics And metalsthe bio-stain deposite layers of cells in a controlled way on artificial scaffolding. Ceres, however, stands out why The organoids will not need scaffolding: they will take advantage of the natural skills from the cell Of organize yourself in spaceforming structures similar to human organs. The cell withdrawn will, in fact, be reprogrammed in induced pluripotent stem cellsthe so -called IPSCwhich are capable of differentiate yourself in any type of fabric.
The project was born within D³4healthan initiative financed by the European Union and the Ministry of University and Research with 126.5 million euros from the National Plan for Complementary Investments to the PNRR. D³4health, promoted by the Sapienza University of Rome, brings together 28 partners Among public and private universities, research and businesses, with the aim of transforming health through advanced digital technologies, such as artificial intelligence and wearable devices. Ceres is one of the winning projects of the waterfall calls issued by the Polytechnic of Turin.
Reserved reproduction © Copyright Ansa
Source: Ansa
I am a journalist with over 6 years of experience working in the news industry. I currently work as an author for Global Happenings, and my coverage focuses on Technology news. I have written for various publications, including Reuters, The New York Times and The Guardian.
